PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy-Reference-Cited by-同舟云学术

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Published:2016-04 Issue:4 Volume:64 Page:800-806
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Papatheodoridis George,Dalekos George,Sypsa Vana,Yurdaydin Cihan,Buti Maria,Goulis John,Calleja Jose Luis,Chi Heng,Manolakopoulos Spilios,Mangia Giampaolo,Gatselis Nikolaos,Keskin Onur,Savvidou Savvoula,de la Revilla Juan,Hansen Bettina E.,Vlachogiannakos Ioannis,Galanis Kostantinos,Idilman Ramazan,Colombo Massimo,Esteban Rafael,Janssen Harry L.A.,Lampertico Pietro

Publisher

Elsevier BV

Subject

Hepatology

Reference27 articles.

1. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

2. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review;Papatheodoridis;J Hepatol,2010

3. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

4. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy;Papatheodoridis;J Hepatol,2015

5. European Organisation for Research and Treatment of Cancer. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma;J Hepatol,2012

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort;Clinical Gastroenterology and Hepatology;2024-09

2. Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection;Journal of Medical Virology;2024-08-29

3. Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility;Journal of Gastroenterology and Hepatology;2024-08-27

4. Disease modifiers and novel markers in HBV-related HCC;Journal of Liver Cancer;2024-08-05

5. Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study;eClinicalMedicine;2024-08